Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Biomechanics|September 20, 2005
Gait dynamics on an inclined walkwayAndrew Stuart McIntosh, Karen T Beatty, Leanne N Dwan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 21, 2026
Reducing locoregional treatments in low risk early invasive breast cancerShelley Potter, Mairead MacKenzie, Stuart McIntosh, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|May 27, 2009
The penile cuff test: A clinically useful non-invasive urodynamic investigation to diagnose men with lower urinary tract symptomsChristopher Harding, Wendy Robson, Michael Drinnan, et al.
Health and Quality of Life Outcomes|October 14, 2011
Pain in castration-resistant prostate cancer with bone metastases: a qualitative studyAdam Gater, Linda Abetz-Webb, Clare Battersby, et al.
British Journal of Sports Medicine|November 26, 2011
Sports helmets now and in the futureAndrew Stuart McIntosh, Thor Einar Andersen, Roald Bahr, et al.
Cancer|July 13, 2012
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to boneJoel B Nelson, Karim Fizazi, Kurt Miller, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|November 19, 2021
Disease recurrence after right hemicolectomy in Scotland: Is there rationale to adopt complete mesocolic excision (CME)?Kiloran H M Metcalfe, Katrina Knight, Stuart McIntosh, et al.
BJU International|September 16, 2010
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trialNicholas D James, Armelle Caty, Heather Payne, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2016
Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled TrialJyothis T George, Rahul Kakkar, Jayne Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancerKarim Fizazi, Karim S Fizazi, Celestia S Higano, et al.
Pageof 3